Cme Group INC Form 4 insider transactions

Director Michael G. Dennis reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.1 per share on June 25, 2024.

Charles P. Carey, a director at CME Group Inc., reported acquiring 1,237 shares of Common Stock Class A on June 25, 2024, at a price of $194.1 per share.

Patrick J. Mulchrone, a director at CME Group Inc., reported acquiring 748 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024.

Howard J. Siegel, a director at CME Group Inc., reports the acquisition of 1,237 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024.

Bryan T. Durkin, a director at CME Group Inc., reported acquiring 748 shares of Class A Common Stock at a price of $194.1 on June 25, 2024, bringing his total holdings to 63,200 shares.

Timothy S. Bitsberger, a director at CME Group Inc., acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Kathryn Benesh, a director at CME Group, acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Director Martin J. Gepsman acquired 748 shares of CME Group Inc. at $194.10 per share on June 25, 2024.

Director Dennis Suskind reports acquiring 748 shares of CME Group Inc. Common Stock Class A at $194.10 per share on June 25, 2024.

Director Daniel G. Kaye acquired 748 shares of CME Group Inc. common stock under the company's Director Stock Plan.

Director Larry G. Gerdes of CME Group Inc. reports the acquisition of 1,237 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024, increasing his total holdings to 40,651.15 shares.

Phyllis M. Lockett, a director of CME Group Inc., reported acquiring 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Director Terry L. Savage reports acquisition of CME Group Inc. shares through a trust.

Director Rahael Seifu reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.1 per share on June 25, 2024, according to a Form 4 filing.

Elizabeth A. Cook, a director of CME Group Inc., acquired 748 shares of Class A Common Stock at a price of $194.1 on June 25, 2024.

Director Deborah J. Lucas acquired 748 shares of CME Group Inc. at a price of $194.1 on June 25, 2024.

Director William W. Hobert reports acquiring 1,237 shares of CME Group Inc. at $194.10 per share.

Director Charles P. Carey sold 3,000 shares of CME Group Inc. stock at a price of $195.44 on June 13, 2024.

Director Daniel Glickman of CME Group Inc. sold 650 shares of Common Stock Class A on June 6, 2024.

Elizabeth A. Cook, a director at CME Group Inc., sold 1,000 shares of Class A Common Stock at a price of $211.52 on May 20, 2024.

Derek Sammann, a Senior Managing Director at CME Group, reported gifting shares of CME Group Class A common stock to his spouse on May 14, 2024.

Director Terry L. Savage sold 2,500 shares of CME Group Inc. Class A Common Stock at a price of $210.6479 on May 13, 2024.

Hilda Harris Piell, a Senior Managing Director and Chief HR Officer at CME Group, recently sold a portion of her holdings in CME Group Class A common stock.

Terrence A. Duffy, Chairman and CEO of CME Group, executed multiple sales of Common Stock Class A on April 29, 2024.

Timothy McCourt, Sr MD Global Head Equity & FX at CME Group, amends his SEC Form 4 to correct a transaction code and reflect adjustments to his beneficially owned shares following a performance share award and tax obligations.

Director William R. Shepard reported acquiring CME Group Inc. Class A common stock through a dividend reinvestment plan and trust.

Timothy McCourt, a Senior Managing Director at CME Group, reported the sale of 35 shares of Common Stock Class A on January 31, 2024.

CME Group's Chief Transformation Officer, Ken Vroman, reports acquisition and disposal of company shares related to a performance share award and tax obligations.

Timothy McCourt, a Senior Managing Director at CME Group, reports acquiring shares from a performance award and surrendering shares for tax obligations.

Julie Holzrichter, Sr MD Chief Operating Officer of CME Group Inc., reports acquisition of shares from a performance award and subsequent disposal to cover tax obligations.